Top Markets
#1 Akedo Akedo +57.65%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.04%
#4 Velvet Velvet +42.35%
#5 Black Phoenix Black Phoenix +34.54%
#6 τemplar τemplar +23.53%
#7 Cross Cross +20.01%
#8 Ribbita by Virtuals Ribbita by Virtuals +16.20%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +15.39%
#10 Perle Perle +15.05%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Classifica tra le azioni #38578
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Prezzo delle azioni
$1.52
Capitalizzazione di mercato
$906.74K
Variazione (1 giorno)
0.58%
Variazione (1 anno)
-88.60%
Paese
US
Scambia Enveric Biosciences, Inc. (ENVB)

Categoria

Healthcare
Rapporto P/B per Enveric Biosciences, Inc. (ENVB)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Enveric Biosciences, Inc., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Enveric Biosciences, Inc. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE